Pregnancy Under Pressure: Oxidative Stress as a Common Thread in Maternal Disorders

Area of Science:

• Reproductive biology
• Biochemistry
• Pathophysiology

Background:

• Oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidant defenses, is implicated in pregnancy complications.
• While moderate ROS aid placental function, excessive ROS cause cellular damage and impair placental health.
• Key pregnancy complications linked to oxidative stress include preeclampsia (PE), gestational diabetes mellitus (GDM), fetal growth restriction (FGR), and recurrent pregnancy loss (RPL).

Purpose of the Study:

• To review current evidence connecting oxidative stress to adverse pregnancy outcomes.
• To highlight established biomarkers of oxidative stress in pregnancy.
• To evaluate the efficacy of antioxidant therapies in improving maternal-fetal health.

Main Methods:

• Literature review synthesizing current research on oxidative stress and pregnancy complications.
• Identification and discussion of key oxidative stress biomarkers, including malondialdehyde (MDA), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and 8-iso-prostaglandin F2α (8-iso-PGF2α).
• Analysis of the effectiveness of antioxidant interventions, such as vitamins C and E, selenium, and folic acid.

Main Results:

• Oxidative stress significantly contributes to the pathogenesis of major pregnancy complications.
• Biomarkers like MDA, 8-OHdG, and 8-iso-PGF2α are indicative of oxidative damage in pregnancy.
• Antioxidant therapies show potential in reducing oxidative markers but yield inconsistent clinical outcomes.

Conclusions:

• Standardized biomarker protocols and personalized treatment strategies are crucial for effective management.
• Further research is needed to optimize antioxidant interventions for improved maternal-fetal health outcomes.
• Addressing individual genetic predispositions and baseline oxidative status is key for future therapeutic approaches.